Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with highly heterogeneous clinical presentations. Among the non-motor features increasingly recognised as clinically relevant ...

In multiple sclerosis, the ability of clinicians to provide a prognosis for a patient and the design and interpretation of clinical trials both rely heavily on prognostic factors identified from ...

While there is currently no cure for multiple sclerosis, researchers continue to discover clues to give a better understanding of how MS happens and how best to treat it.

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

In 2024, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress celebrated a remarkable 40 years of pioneering work. Regional committees have emerged around the ...